Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study model. (2014)

First Author: Fenaux P
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 24360612

Publication URI:

Type: Journal Article/Review

Volume: 38

Parent Publication: Leukemia research

Issue: 2

ISSN: 0145-2126